James Oliviero Insider Profile

4 Followers
James Oliviero, Chief Financial Officer at Keryx Biopharma, holds 2.73M shares in Checkpoint Therapeutics (Ticker: CKPT), holds 209.41K shares in Keryx Biopharma (Ticker: KERX).
tipranks
James Oliviero

James Oliviero
Keryx Biopharma (KERX)
Chief Financial Officer

Ranked #68,207 out of 78,624 Corporate Insiders

Profitable Transactions

44%
17 out of 39 Profitable Transactions

Average Return

-9.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
100.00%
A breakdown of James Oliviero's holdings

Insider Roles

Checkpoint Therapeutics
(CKPT)
CEO, President and Director, Director
Roles that James Oliviero holds in companies

Most Profitable Insider Trade

Stock:
Keryx Biopharma
(KERX)
Rating:Informative Buy
Date:May 22, 2009 - May 22, 2010
Return:+692.80%
The most profitable trade made by James Oliviero

James Oliviero's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KERX
Keryx Biopharma
Jul 08, 2015
Informative Sell
18.67K
$703.60K
Checkpoint Therapeutics
Feb 25, 2020
CEO, President and Director, Director
Uninformative Buy
$6.48M
List of latest transactions for each holding click on a transaction to see James Oliviero's performance on stock

James Oliviero insider profile FAQ

What is the percentage of profitable transactions made by James Oliviero?
The percentage of profitable transactions made by James Oliviero is 44%.
    What is the average return per transaction made by James Oliviero?
    The average return per transaction made by James Oliviero is -9.30%.
      What stocks does James Oliviero hold?
      James Oliviero holds: KERX, CKPT stocks.
        What was James Oliviero’s latest transaction?
        James Oliviero latest transaction was an Uninformative Buy of ―.
          What was James Oliviero's most profitable transaction?
          James Oliviero’s most profitable transaction was an Informative Buy of KERX stock on May 22, 2009. The return on the trade was 692.80%.
            What is James Oliviero's role in Keryx Biopharma?
            James Oliviero's role in Keryx Biopharma is Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.